1. Market Research
  2. > Biotechnology
  3. > Biopharmaceutical Market Trends
  4. > Biopharmaceutical Analysis & Statistics, August 2016

Biopharmaceutical Analysis & Statistics, August 2016

24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Publishers

All regions

1-30 of about 3 400 reports

Purchase Reports From Reputable Market Research Publishers

Hospital Acquired Methicillin-Resistant Staphylococcus aureus (HA-MRSA) Infections - Pipeline Review, H1 2016

Hospital Acquired Methicillin-Resistant Staphylococcus aureus (HA-MRSA) Infections - Pipeline Review, H1 2016

  • $ 42 529
  • Company report
  • June 2016
  • by Global Markets Direct

Hospital Acquired Methicillin-Resistant Staphylococcus aureus (HA-MRSA) Infections - Pipeline Review, H1 2016 Summary Global Markets Direct’s, ‘Hospital Acquired Methicillin-Resistant Staphylococcus ...

  • Industries : Therapy, Pharmaceutical
  • Countries : World, United Kingdom, United States
Toxoplasmosis - Pipeline Review, H1 2016

Toxoplasmosis - Pipeline Review, H1 2016

  • $ 42 529
  • Company report
  • June 2016
  • by Global Markets Direct

Toxoplasmosis - Pipeline Review, H1 2016 Summary Global Markets Direct’s, ‘Toxoplasmosis - Pipeline Review, H1 2016’, provides an overview of the Toxoplasmosis pipeline landscape. The report provides ...

  • Industries : Pathology, Biopharmaceutical, Therapy
  • Countries : World
Poliomyelitis - Pipeline Review, H1 2016

Poliomyelitis - Pipeline Review, H1 2016

  • $ 42 529
  • Company report
  • June 2016
  • by Global Markets Direct

Poliomyelitis - Pipeline Review, H1 2016 Summary Global Markets Direct’s, ‘Poliomyelitis - Pipeline Review, H1 2016’, provides an overview of the Poliomyelitis pipeline landscape. The report provides ...

  • Industries : Pathology, Therapy, Biopharmaceutical, Healthcare
  • Countries : United States, World
Type 1 diabetes (Juvenile Diabetes) - Pipeline Review, H1 2016

Type 1 diabetes (Juvenile Diabetes) - Pipeline Review, H1 2016

  • $ 42 529
  • Company report
  • June 2016
  • by Global Markets Direct

Type 1 diabetes (Juvenile Diabetes) - Pipeline Review, H1 2016 Summary Global Markets Direct’s, ‘Type 1 Diabetes (Juvenile Diabetes) - Pipeline Review, H1 2016’, provides an overview of the Type ...

  • Industries : Chronic Disease, Pathology
  • Countries : United States
Herpes Simplex Virus (HSV) Infections - Pipeline Review, H1 2016

Herpes Simplex Virus (HSV) Infections - Pipeline Review, H1 2016

  • $ 42 529
  • Company report
  • June 2016
  • by Global Markets Direct

Herpes Simplex Virus (HSV) Infections - Pipeline Review, H1 2016 Summary Global Markets Direct’s, ‘Herpes Simplex Virus (HSV) Infections - Pipeline Review, H1 2016’, provides an overview of the Herpes ...

  • Industries : Therapy, Biopharmaceutical, Pharmaceutical, Pathology, Research and Development, Biotechnology
  • Countries : United States
Sangamo BioSciences, Inc. - Product Pipeline Review - 2016

Sangamo BioSciences, Inc. - Product Pipeline Review - 2016

  • $ 42 529
  • Company report
  • June 2016
  • by Global Markets Direct

Sangamo BioSciences, Inc. - Product Pipeline Review - 2016 Summary Global Markets Direct’s, ‘Sangamo BioSciences, Inc. - Product Pipeline Review - 2016’, provides an overview of the Sangamo BioSciences, ...

  • Industries : Research and Development, Biological Therapy, Pathology, Therapy
  • Countries : United States
Nanotherapeutics, Inc. - Product Pipeline Review - 2016

Nanotherapeutics, Inc. - Product Pipeline Review - 2016

  • $ 42 529
  • Company report
  • June 2016
  • by Global Markets Direct

Nanotherapeutics, Inc. - Product Pipeline Review - 2016 Summary Global Markets Direct’s, ‘Nanotherapeutics, Inc. - Product Pipeline Review - 2016’, provides an overview of the Nanotherapeutics, Inc.’s ...

  • Industries : Therapy, Pathology, Biopharmaceutical, Research and Development
  • Countries : United States
Kidney Cancer (Renal Cell Cancer) - Pipeline Review, H1 2016

Kidney Cancer (Renal Cell Cancer) - Pipeline Review, H1 2016

  • $ 42 529
  • Company report
  • June 2016
  • by Global Markets Direct

Kidney Cancer (Renal Cell Cancer) - Pipeline Review, H1 2016 Summary Global Markets Direct’s, ‘Kidney Cancer (Renal Cell Cancer) - Pipeline Review, H1 2016’, provides an overview of the Kidney Cance ...

  • Industries : Cancer, Pathology
  • Countries : United States
Streptococcal Pneumonia - Pipeline Review, H1 2016

Streptococcal Pneumonia - Pipeline Review, H1 2016

  • $ 42 529
  • Company report
  • June 2016
  • by Global Markets Direct

Streptococcal Pneumonia - Pipeline Review, H1 2016 Summary Global Markets Direct’s, ‘Streptococcal Pneumonia - Pipeline Review, H1 2016’, provides an overview of the Streptococcal Pneumonia pipeline ...

  • Industries : Pathology, Biopharmaceutical, Therapy, Healthcare
  • Countries : World
Mucopolysaccharidosis III (MPS III) (Sanfilippo Syndrome ) - Pipeline Review, H1 2016

Mucopolysaccharidosis III (MPS III) (Sanfilippo Syndrome ) - Pipeline Review, H1 2016

  • $ 42 529
  • Company report
  • June 2016
  • by Global Markets Direct

Mucopolysaccharidosis III (MPS III) (Sanfilippo Syndrome ) - Pipeline Review, H1 2016 Summary Global Markets Direct’s, ‘Mucopolysaccharidosis III (MPS III) (Sanfilippo Syndrome ) - Pipeline Review, ...

  • Industries : Pathology, Therapy, Pharmaceutical, Healthcare
  • Countries : United States
Age Related Macular Degeneration - Pipeline Review, H1 2016

Age Related Macular Degeneration - Pipeline Review, H1 2016

  • $ 42 521
  • Company report
  • May 2016
  • by Global Markets Direct

Age Related Macular Degeneration - Pipeline Review, H1 2016 Summary Global Markets Direct’s, ‘Age Related Macular Degeneration - Pipeline Review, H1 2016’, provides an overview of the Age Related ...

  • Industries : Pathology, General Medicine and Specialty Medicine, Healthcare
  • Countries : United States
Cervical Intraepithelial Neoplasia (CIN) - Pipeline Review, H1 2016

Cervical Intraepithelial Neoplasia (CIN) - Pipeline Review, H1 2016

  • $ 42 521
  • Company report
  • May 2016
  • by Global Markets Direct

Cervical Intraepithelial Neoplasia (CIN) - Pipeline Review, H1 2016 Summary Global Markets Direct’s, ‘Cervical Intraepithelial Neoplasia (CIN) - Pipeline Review, H1 2016’, provides an overview of ...

  • Industries : Therapy, Biopharmaceutical, Biological Therapy, Biotechnology
  • Countries : United States
Global Cancer Diagnostics Market New Frontiers, Business Challenges, Emerging Technologies, Competitive Landscape

Global Cancer Diagnostics Market New Frontiers, Business Challenges, Emerging Technologies, Competitive Landscape

  • $ 21 100
  • Industry report
  • July 2016
  • by Venture Planning Group

Complete report $34,750.  DataPack (test volumes, sales forecasts, supplier shares) $21,100. VPGMarketResearch.com's new report is a study of the major business opportunities emerging in the global cance ...

  • Industries : Biopharmaceutical
  • Countries : United States
Cancer Diagnostics: A Market on the Verge of Explosion--Technological Breakthroughs, Emerging Tests, Market Forecasts, Competitive Intelligence

Cancer Diagnostics: A Market on the Verge of Explosion--Technological Breakthroughs, Emerging Tests, Market Forecasts, Competitive Intelligence

  • $ 15 900
  • Industry report
  • August 2016
  • by Venture Planning Group

Complete report $24,500.  DataPack (test volumes, sales forecasts, supplier shares) $15,900. VPGMarketResearch’s new report is a study of the major business opportunities emerging in the global cance ...

  • Industries : Biopharmaceutical
Europe Cancer Diagnostics Market New Frontiers, Business Challenges, Emerging Technologies, Competitive Landscape

Europe Cancer Diagnostics Market New Frontiers, Business Challenges, Emerging Technologies, Competitive Landscape

  • $ 12 800
  • Industry report
  • July 2016
  • by Venture Planning Group

Complete report $19,700.  DataPack (test volumes, sales forecasts, supplier shares) $12,800. VPGMarketResearch’s new report is a study of the major business opportunities emerging in the European cance ...

  • Industries : Biopharmaceutical
Tumor Markers: France, Germany, Italy, Spain, UK--Market Analysis, Competitive Intelligence, Technology Trends, Opportunities for Suppliers

Tumor Markers: France, Germany, Italy, Spain, UK--Market Analysis, Competitive Intelligence, Technology Trends, Opportunities for Suppliers

  • $ 12 800
  • Industry report
  • June 2016
  • by Venture Planning Group

Complete report $19,700. DataPack (test volumes, sales forecasts, supplier shares) $12,800. Summary This comprehensive five-country report contains 820 pages, 320 tables, and presents analysis of the ...

  • Industries : Biopharmaceutical
Cancer Diagnostics Market:  France, Germany, Italy, Spain, UK--Market Analysis, Competitive Intelligence, Technology Trends, Opportunities for Suppliers

Cancer Diagnostics Market: France, Germany, Italy, Spain, UK--Market Analysis, Competitive Intelligence, Technology Trends, Opportunities for Suppliers

  • $ 12 800
  • Industry report
  • June 2016
  • by Venture Planning Group

This comprehensive five-country report contains 820 pages, 320 tables, and presents analysis of the major business opportunities emerging in the cancer diagnostics market during the next five years. The ...

  • Industries : Biopharmaceutical
  • Countries : France
Prostate Cancer Pricing, Reimbursement, and Access

Prostate Cancer Pricing, Reimbursement, and Access

  • $ 7 500
  • Industry report
  • July 2016
  • by Datamonitor Healthcare

Novel antiandrogens will need to present risk-sharing agreements in EU markets, while discussing contracting with US payers to ensure a competitive advantage. Vaccines suffer from inconclusive response ...

  • Industries : Therapy, Cancer
  • Countries : Europe, United States, Spain, United Kingdom, France
Psoriatic Arthritis Pricing, Reimbursement, and Access

Psoriatic Arthritis Pricing, Reimbursement, and Access

  • $ 7 500
  • Industry report
  • June 2016
  • by Datamonitor Healthcare

An absence of head-to-head trials, along with biosimilar launches, provide payers with leverage to demand favorable pricing for branded products in exchange for formulary access. This report addresses ...

  • Industries : Pathology, Healthcare
  • Countries : Europe, Spain, Germany, Italy
Medical Affiars Reputation: Multiple Sclerosis (US)

Medical Affiars Reputation: Multiple Sclerosis (US)

  • $ 6 320
  • Industry report
  • June 2016
  • by Firstword Pharma

MS medical affairs: oral therapies outperforming in the US. How does your team measure up? In the US multiple sclerosis (MS) market, medical affairs teams for oral therapies outperform their platform-therapy ...

  • Industries : Biopharmaceutical
Medical Affiars Reputation: Multiple Sclerosis (EU5)

Medical Affiars Reputation: Multiple Sclerosis (EU5)

  • $ 6 320
  • Industry report
  • June 2016
  • by Firstword Pharma

MS medical affairs: oral therapies outperforming in Europe. How does your team measure up? In Europe’s Multiple Sclerosis (MS) market, medical affairs teams for oral therapies outperform their platform-therapy ...

  • Industries : Biopharmaceutical
  • Countries : Europe
Frontier Pharma: Hematological Cancers - Highly Innovative Pipeline Continues Trend towards Targeted, Patient-Specific Therapies

Frontier Pharma: Hematological Cancers - Highly Innovative Pipeline Continues Trend towards Targeted, Patient-Specific Therapies

  • $ 6 995
  • Industry report
  • June 2016
  • by GBI Research

Frontier Pharma: Hematological Cancers - Highly Innovative Pipeline Continues Trend towards Targeted, Patient-Specific Therapies Summary Hematological malignancies are a class of cancer that affect the ...

  • Industries : Cancer, Pathology
  • Countries : World
US Cancer Diagnostics Market Analysis, Competitive Intelligence, Technology Trends, Opportunities for Suppliers

US Cancer Diagnostics Market Analysis, Competitive Intelligence, Technology Trends, Opportunities for Suppliers

  • $ 6 400
  • Industry report
  • June 2016
  • by Venture Planning Group

VPGMarketResearch.com's new report is a strategic analysis of the major business opportunities emerging in the cancer diagnostics market during the next five years. The report examines trends in the ...

  • Industries : Biopharmaceutical
Plasma Protein Therapeutics Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2016 - 2024

Plasma Protein Therapeutics Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2016 - 2024

  • $ 5 795
  • Industry report
  • July 2016
  • by Transparency Market Research

Plasma derived proteins are biological medicines used extensively in the treatment of rare, life-threatening, chronic, and genetic diseases. This report on the global plasma protein therapeutics market ...

  • Industries : Biopharmaceutical, Pathology, Therapy
  • Countries : World
Veterinary/Animal Vaccines Market Product,, Poultry, Aquaculture, Diseases, Technology - Forecast to 2021

Veterinary/Animal Vaccines Market Product,, Poultry, Aquaculture, Diseases, Technology - Forecast to 2021

  • $ 5 650
  • Industry report
  • August 2016
  • by MarketsandMarkets

“Veterinary/Animal Vaccines Market, Product [Porcine, (Companion-Canine), (Livestock-Bovine), Poultry, Aquaculture], Diseases [Rabies, FMD, Swine Influenza, Strangles, Furunculosis], Technology [DNA, ...

  • Industries : Therapy, Biopharmaceutical, Pharmaceutical, Biotechnology
  • Countries : Asia, World
Vaccines Market by Technology, Disease Indication, End User & Type - Forecasts to 2021

Vaccines Market by Technology, Disease Indication, End User & Type - Forecasts to 2021

  • $ 5 650
  • Industry report
  • August 2016
  • by MarketsandMarkets

The vaccines market is expected to reach USD 48.03 billion by 2021 from USD 32.24 billion in 2016 at a CAGR of 8.3%. The global vaccines market is segmented based on technology, type, disease indication, ...

  • Industries : Biopharmaceutical, Therapy
  • Countries : North America, World, Asia
Plasma Fractionation Market by Product, Application, End User - Global Forecast to 2021

Plasma Fractionation Market by Product, Application, End User - Global Forecast to 2021

  • $ 5 650
  • Industry report
  • August 2016
  • by MarketsandMarkets

The global plasma fractionation market is estimated to grow at a CAGR of 6.7% from 2016 to 2021, to reach USD 26.07 billion by 2021 from USD 18.84 billion in 2016. Growth in this market is mainly attributed ...

  • Industries : Blood Supply, Tissue Banking and Transplantation, Healthcare
  • Countries : World, Europe, Asia
Multiplex Assays Market by Product ), Type , Technology , Application , End User  - Global Forecast to 2021

Multiplex Assays Market by Product ), Type , Technology , Application , End User - Global Forecast to 2021

  • $ 5 650
  • Industry report
  • August 2016
  • by MarketsandMarkets

Adoption of Companion Diagnostics for Increasing Efficacy of Therapies, Advantages of Multiplexing Over Traditional Assays, and Need for Effective Analytical Platforms in Research to Reduce Operational ...

  • Industries : In Vitro Diagnostics, Medical Device
  • Countries : World, North America
Food Enzymes Market by Type, Application, Source, Form, & by Region - Global Forecasts to 2021

Food Enzymes Market by Type, Application, Source, Form, & by Region - Global Forecasts to 2021

  • $ 5 650
  • Industry report
  • July 2016
  • by MarketsandMarkets

“Food enzymes market is projected to grow at a CAGR of 7.4% in terms of value” This report analyzes the food enzymes market, in terms of type, application, source, formulation, and region. The food ...

  • Industries : Biopharmaceutical, Food, Biotechnology
  • Countries : World, Europe, Asia, North America
Vaccine Adjuvants Market by Product Type , Route of Administration , Disease Type , Application  & Application Category - Forecasts to 2021

Vaccine Adjuvants Market by Product Type , Route of Administration , Disease Type , Application & Application Category - Forecasts to 2021

  • $ 5 650
  • Industry report
  • June 2016
  • by MarketsandMarkets

The vaccine adjuvants market is expected to reach USD 769.4 million by 2021 from USD 467.0 million in 2016, at a CAGR of 10.5%. The global vaccine adjuvants market is segmented based on product type, route ...

  • Industries : Biopharmaceutical, Therapy, Pharmaceutical, Biotechnology
  • Countries : World

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.